M42’s Diaverum showcases commitment to a sustainable future of health at Global Health Exhibition 2024 in Saudi Arabia
- Diaverum has been at the forefront of transforming renal care in the Kingdom for over a decade
- A series of panel discussions will feature M42 experts from its world-leading facilities, such as Diaverum, Imperial College London Diabetes Centre and National Reference Laboratory, Cleveland Clinic Abu Dhabi, as well as M42’s AI and Applied Sciences team
- The ‘For Life’ stand will showcase Diaverum’s achievements in patient care and medical excellence as well as its contributions to the Kingdom’s healthcare landscape
Diaverum Saudi Arabia, part of the M42 group, returns to the Global Health Exhibition in Riyadh, showcasing its mission of “For Life – for a Sustainable Future of Health.” At the event, visitors will explore Diaverum’s dedication to sustainable healthcare through engaging discussions on value-based care, healthcare innovation and strategic partnerships.
Diaverum has been at the forefront of transforming renal care in Saudi Arabia for over a decade, being the largest renal care provider in the Kingdom, now providing world-class dialysis services across 33 cities.
With M42’s backing, Diaverum continues to innovate with a tech-enabled, personalized approach that aligns with Saudi Vision 2030, promoting sustainability and improving healthcare both regionally and globally.
Ziyad Kabli, Senior Vice President – Middle East at Diaverum said: “We are highlighting Diaverum’s transformative role in healthcare at this important exhibition as part of Saudi Arabia’s ambitious transformation agenda.
Our standardized care delivery model ensures we continuously improve value provided to the healthcare system as well as clinical outcomes while expanding access to the best possible care.
With M42’s cutting-edge technologies and facilities, we’re helping to reshape healthcare in the Kingdom in line with Vision 2030, offering real value to patients through superior medical care and impactful results on their quality of life”
Under the event theme of ‘Invest in Health,’ Diaverum’s “For Life” stand will not only showcase Diaverum’s achievements in patient care and medical excellence but also its contributions to the sustainability of the future of the Kingdom’s healthcare landscape, including investments in education, research and Saudization efforts.
It will also spotlight the role Diaverum plays in a value-based, public-private partnership model, aligned with Vision 2030 to expand access to care across Saudi Arabia.
A series of panel discussions will feature M42 experts and its world-class facilities, such as Diaverum, Imperial College London Diabetes Centre (ICLDC), National Reference Laboratory (NRL), Cleveland Clinic Abu Dhabi and the M42’s AI and Applied Sciences team.
Discussions include ‘Value-Based Healthcare in Chronic Disease Management’ and ‘Integrating Genomics into Preventive Care Strategies,’ offering visitors valuable insights into the future of healthcare.
A highlight of the exhibition will be the debut of M42’s Med42 in Saudi Arabia. This AI-driven tool, powered by 70 billion parameters, is designed to support clinicians and patients by synthesizing vast amounts of medical data in real time, making it an essential resource for healthcare professionals.
The Global Health Exhibition, taking place at the Riyadh Convention & Exhibition Centre from October 21 – 23, is Saudi Arabia’s premier healthcare event. It will host more than 500 speakers and features more than 1200 global and local exhibiting companies.
The event serves as a critical platform for thought leadership, technological innovation and major healthcare announcements across the region. The Diaverum stand will be located at H1C-V40.
